DV
Dividend Vision

BLCO — Bausch + Lomb Corp

Bausch + Lomb Corp (BLCO)

Total return is -5.3% over the past 4.3 years, 104.1 points behind SPY at 98.8%. Its deepest 1-year drawdown was 20.1%.

BLCO is a single-stock equity holding in Bausch + Lomb Corp, a healthcare company, rather than a diversified ETF. The fund does not currently display dividend distribution data, and key metrics including expense ratio and assets under management are not available. This holding appeals primarily to investors seeking exposure to a specific healthcare company, though the absence of standard ETF characteristics and distribution information limits its utility as an income-focused investment vehicle.

BLCO key facts

Asset type
Stock
Asset class
Equity
Inception date
05/05/2022
Last close
$17.05
Market cap
$5,797,281,280
Average volume
237052.0
Beta
0.558
Payout ratio
0.0
Forward P/E
14.3678
EPS
$-0.62